Apogem Capital Closes $597M Private Equity Fund XI at Hard Cap
Apogem Capital announces the final close of its eleventh private equity fund, APEF XI, reaching its hard cap with $597M in committed capital from investors.
Press Release Disclaimer: This is a press release distributed through the XPR Media network. It has not been independently verified by our newsroom.
Apogem Capital (“Apogem”), a leading private markets investor, today announced the final close of Apogem Private Equity Fund XI (“APEF XI” or the “Fund”), hitting the Fund’s hard cap with $580 million committed from Limited Partners. Employees committed an additional $17 million, bringing total committed capital to $597 million and reflecting strong investor support for Apogem’s differentiated approach to accessing opportunities in the lower middle market.
APEF XI continues the firm’s long-established lower middle market strategy, building portfolios of diversified exposure across emerging fund managers, independent sponsors, and direct investments in North America. Apogem has a proven, 25+ year track record investing in this market segment, providing clients with access to what we believe to be one of the most attractive yet difficult to navigate segments of private equity.
Louise Smith, Managing Director and Co-Head of Fund Investments at Apogem Capital, said:
“We are grateful for the continued support of our longstanding investors and are pleased to welcome new institutional partners to APEF XI. We believe exposure to emerging managers and the lower middle market can add alpha and diversification to institutional private equity portfolios, with the added benefit of resilience in challenging environments.”
The Fund received strong support from existing limited partners and attracted commitments from a diverse group of global institutional investors, including public and private pension plans, family offices, and RIAs. Apogem employees and its parent company, New York Life Insurance Company, also made meaningful commitments to the Fund.
Richard Wiltshire, Managing Director and Head of Co-investments, added:
“Despite macroeconomic uncertainty and market volatility, we continue to find compelling opportunities in the lower middle market where activity levels and distributions have remained resilient. APEF XI is positioned to capitalize on the breadth of opportunities we see across emerging managers, independent sponsors and direct investments, while maintaining the discipline that has guided our approach through multiple market cycles.”
APEF XI benefits from Apogem’s scale and platform connectivity as a $44 billion private markets investment manager.1 The Fund draws on the firm’s deep lower middle market relationships established over the last 25+ years across its private equity and credit programs.
About Apogem Capital
Apogem Capital is a leading private markets investor with 35 years of expertise across private credit and private equity in North America. As of June 30, 2026, the firm manages approximately $44 billion in assets.1 Apogem provides a comprehensive suite of solutions, including direct lending, private equity funds and co-investments, GP-led transactions and LP secondaries, GP stakes, and private real assets.
With a team of over 250 professionals, including more than 120 investment professionals, Apogem combines deep domain expertise with the stability and long-term perspective of its parent company, New York Life Insurance Company. Apogem Capital is a wholly owned subsidiary of New York Life through New York Life Investment Management Holdings, LLC.
For more information, visit apogemcapital.com.
- AUM is estimated and unaudited as of June 30, 2026, and includes non-discretionary and co-advised assets.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260908500820/en/
Media gallery
